
AnaptysBio ANAB
$ 65.73
5.44%
Annual report 2025
added 03-03-2026
AnaptysBio Long Term Debt Current 2011-2026 | ANAB
Annual Long Term Debt Current AnaptysBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.08 M | 1.92 M | 1.78 M | 1.64 M | 1.5 M | 342 K | 871 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.08 M | 342 K | 1.45 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.88 | -1.69 % | $ 6.47 M | ||
|
Aquestive Therapeutics
AQST
|
631 K | $ 4.1 | 1.23 % | $ 438 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
9.96 M | $ 22.45 | 1.13 % | $ 3.72 B | ||
|
Athira Pharma
ATHA
|
465 K | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
3.29 M | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
1.37 M | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
2.81 M | - | - | $ 3.74 B | ||
|
Cerus Corporation
CERS
|
2.9 M | $ 2.03 | 5.73 % | $ 387 M | ||
|
Caladrius Biosciences
CLBS
|
137 K | - | -16.75 % | $ 25.8 M | ||
|
Aeterna Zentaris
AEZS
|
215 K | - | 5.93 % | $ 314 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 103.45 | 1.85 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
208 K | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.5 M | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.18 M | - | - | $ 2.02 B | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
3.25 M | - | - | $ 28.6 M | ||
|
Editas Medicine
EDIT
|
6.03 M | $ 3.0 | 6.38 % | $ 266 M | ||
|
Edesa Biotech
EDSA
|
19.9 K | $ 18.27 | 14.94 % | $ 58.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 3.19 | 6.69 % | $ 5.25 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
84 K | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
712 K | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M |